Sanofi India Ltd vs Source Natural Foods Herbal Supplements Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Sanofi India Ltd is ₹ 3402 as of 05 May 15:30 . The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023 .The P/E Ratio of Source Natural Foods & Herbal Supplements Ltd is 0 as of December 2023 . The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023 .The Market Cap of Source Natural Foods & Herbal Supplements Ltd is ₹ 0 crore as of December 2023 . The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 .The Revenue of Source Natural Foods & Herbal Supplements Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 .The EBITDA of Source Natural Foods & Herbal Supplements Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 .The Net Profit of Source Natural Foods & Herbal Supplements Ltd is ₹ 0 crore as of Jun '24 . The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Source Natural Foods & Herbal Supplements Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

About Source Natural Foods & Herbal Supplements Ltd

Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995.
The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12.
The Company engages in the pharmaceutical business in India.
It provides allopathic and ayurvedic formulations.
Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets. Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country.

FAQs for the comparison of Sanofi India Ltd and Source Natural Foods & Herbal Supplements Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Source Natural Foods & Herbal Supplements Ltd?

Market cap of Sanofi India Ltd is 8,111 Cr while Market cap of Source Natural Foods & Herbal Supplements Ltd is 83 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Source Natural Foods & Herbal Supplements Ltd?

The stock performance of Sanofi India Ltd and Source Natural Foods & Herbal Supplements Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Source Natural Foods & Herbal Supplements Ltd?

As of May 5, 2026, the Sanofi India Ltd stock price is INR ₹3522.25. On the other hand, Source Natural Foods & Herbal Supplements Ltd stock price is INR ₹129.95.

How do dividend payouts of Sanofi India Ltd and Source Natural Foods & Herbal Supplements Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Source Natural Foods & Herbal Supplements Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.